Cargando…
The “COVID-19 Pandemic Gap” and Its Influence on Oncologic Outcomes of Bladder Cancer
SIMPLE SUMMARY: The COVID-19 pandemic has had a major impact on the entire healthcare system, resulting in severe restrictions of nonemergency clinical services, as well as in the clinical practice of uro-oncology. We performed a retrospective analysis to evaluate outcomes of the COVID-19 pandemic r...
Autores principales: | Tulchiner, Gennadi, Staudacher, Nina, Fritz, Josef, Radmayr, Christian, Culig, Zoran, Horninger, Wolfgang, Pichler, Renate |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067623/ https://www.ncbi.nlm.nih.gov/pubmed/33916962 http://dx.doi.org/10.3390/cancers13081754 |
Ejemplares similares
-
CMTM6 expression as a potential biomarker for immunotherapy in metastatic renal cell carcinoma
por: Tulchiner, Gennadi, et al.
Publicado: (2021) -
Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance in Comparison to Urinary Cytology: Results from a Prospective Single-Center Study
por: Pichler, Renate, et al.
Publicado: (2017) -
Long term disease free survival with multimodal therapy in small cell bladder cancer
por: Heidegger, Isabel, et al.
Publicado: (2016) -
Do we need repeated CT imaging in uncomplicated blunt renal injuries? Experiences of a high-volume urological trauma centre
por: Lindner, Andrea Katharina, et al.
Publicado: (2022) -
Organ-Sparing Surgery in Testicular Tumor: Is This the Right Approach for Lesions ≤ 20 mm?
por: Staudacher, Nina, et al.
Publicado: (2020)